Results
1 -
8 of
8
(Click
here to explore results)
- New Tools to Interrogate Endocannabinoid Signalling: From Natural Compounds to Synthetic Drugs, Chapter 7 Inhibition of NAPE-PLD Activity by Natural Compounds and Synthetic Drugs, and Its Biological Relevance. K. Tsuboi, T. Uyama, N. Ueda
, 2021
, Pages 301-336
- New Tools to Interrogate Endocannabinoid Signalling: From Natural Compounds to Synthetic Drugs, Chapter 8 Natural Compounds and Synthetic Drugs to Target FAAH Enzyme. S. Butini, S. Gemma, G. Campiani
, 2021
, Pages 337-384
- New Tools to Interrogate Endocannabinoid Signalling: From Natural Compounds to Synthetic Drugs, Chapter 2 Phytocannabinoids Versus Endocannabinoids. A Modern View of the Endocannabinoid System. Javier Fernández-Ruiz, Onintza Sagredo, Eva de Lago
, 2021
, Pages 10-47
- New Tools to Interrogate Endocannabinoid Signalling: From Natural Compounds to Synthetic Drugs, Subject Index
, 2021
, Pages 451-457
- New Tools to Interrogate Endocannabinoid Signalling: From Natural Compounds to Synthetic Drugs, Chapter 10 Small-molecule Inhibitors of Endocannabinoid Transport and Trafficking. Inés Reynoso Moreno, Jürg Gertsch
, 2021
, Pages 414-450
- New Tools to Interrogate Endocannabinoid Signalling: From Natural Compounds to Synthetic Drugs, Chapter 5 Natural and Synthetic Cannabinoids Targeting Non-CB1, Non-CB2 G Protein-coupled Receptors. Paula Morales, Israa H. Isawi, Patricia H. Reggio
, 2021
, Pages 168-200
- New Tools to Interrogate Endocannabinoid Signalling: From Natural Compounds to Synthetic Drugs, Chapter 6 Natural Compounds and Synthetic Drugs Targeting the Ionotropic Cannabinoid Members of Transient Receptor Potential (TRP) Channels. Rosa Maria Vitale, Aniello Schiano Moriello, Luciano De Petrocellis
, 2021
, Pages 201-300
- Acute Brain Impairment: Scientific Discoveries and Translational Research, Chapter 5 Neuroprotective Therapies for Ischemic Stroke. Yolanda Cruz, Karla Cantu-Saldaña, Antonio Ibarra
, 2018
, Pages 64-81